Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Hematologic Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 14 Lung Neoplasms 10 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Breast Neoplasms 7 Stomach Neoplasms 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic cancer, adult 2 Ovarian Neoplasms 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1 Skin Neoplasms 1

Interventions

Ipilimumab 25 Nivolumab 19 pembrolizumab 11 incomplete Freund's adjuvant 10 Melphalan 9 Cyclophosphamide 9 Interleukin-2 8 sargramostim 7 MART-1 Antigen 7 CTLA-4 Antigen 7 tebentafusp 6 Temozolomide 6 Ranibizumab 6 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Dacarbazine 5 Blood Specimen Collection 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Biopsy 4 Bevacizumab 4 trametinib 3 sotrastaurin 3 fludarabine phosphate 3 fludarabine 3 binimetinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04424719 2025-09-03

SALOME

Institut Curie

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡